Cargando…

Inducible nitric oxide synthase as a potential blood-based biomarker in inflammatory bowel diseases

AIM: Here, we evaluated the role of (iNOS) as a blood-based biomarker of inflammatory bowel diseases (IBD). BACKGROUND: Up-regulation of inducible nitric oxide synthase (iNOS) in the intestinal epithelial cells has been closely associated with the initiation and maintenance of intestinal inflammatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baranipour, Saeed, Amini Kadijani, Azade, Qujeq, Durdi, Shahrokh, Shabnam, Haghazali, Mehrdad, Mirzaei, Alireza, Asadzadeh-Aghdaei, Hamid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347994/ https://www.ncbi.nlm.nih.gov/pubmed/30774818

Ejemplares similares

The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study
por: Azramezani Kopi, Tayebeh, et al.
Publicado: (2019)

Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
por: Amini Kadijani, Azade, et al.
Publicado: (2017)

Erratum: Transmembrane TNF-α Density, But Not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
por: Amini Kadijani, Azade, et al.
Publicado: (2017)

Apoptosis markers of circulating leukocytes are associated with the clinical course of inflammatory bowel disease
por: Amini Kadijani, Azade, et al.
Publicado: (2018)

Nitric oxide and inducible nitric oxide synthase levels in EE and NERD patients
por: Nejat PishKenari, Fatemeh, et al.
Publicado: (2022)

Efficacy and Safety of Melatonin as an Adjunctive Therapy on Clinical, Biochemical, and Quality of Life in Patients with Ulcerative Colitis
por: Shahrokh, Shabnam, et al.
Publicado: (2021)

Risk of infection in postmenopausal women with rheumatoid arthritis and osteoporosis taking denosumab and bDMARDS
por: Mirzaei, Alireza, et al.
Publicado: (2021)

Calprotectin in inflammatory bowel disease
por: Khaki-Khatibi, Fatemeh, et al.
Publicado: (2020)

Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic
por: Moein, Soheila, et al.
Publicado: (2017)

Sequence variations of Epstein–Barr virus LMP1 gene in gastric cancer and chronic gastritis isolates from Iranian patients
por: Sarshari, Behrang, et al.
Publicado: (2022)

Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results
por: Hossein-khannazer, Nikoo, et al.
Publicado: (2021)

Translation and cross-cultural adaptation of the Persian version of inflammatory bowel disease-fatigue (IBD-F) self-assessment questionnaire
por: Hatamnejad, Mohammad Reza, et al.
Publicado: (2023)

Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice
por: Hatamnejad, Mohammad Reza, et al.
Publicado: (2022)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

Association between variants of the autophagy related gene ATG16L1 in inflammatory bowel diseases and clinical statues
por: Baradaran Ghavami, Shaghayegh, et al.
Publicado: (2019)

Overview of Three Proliferation Pathways (Wnt, Notch, and Hippo) in Intestine and Immune System and Their Role in Inflammatory Bowel Diseases (IBDs)
por: Khoramjoo, Seyed Mobin, et al.
Publicado: (2022)

Association between Serum folate with inflammatory markers, disease clinical activity and serum homocysteine in patients with Inflammatory Bowel Disease. Does folate level have an effect on maintaining clinical remission?
por: Moein, Soheila, et al.
Publicado: (2020)

Sensitivity and specificity of mean platelet volume as a laboratory marker for irritable bowel syndrome: Can it be added to Rome criteria?
por: Vaghari-Tabari, Mostafa, et al.
Publicado: (2020)

Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2020)

Description of the inflammatory bowel disease natural history in Tehran province, Iran: Mixed panel approaches
por: Olfatifar, Meysam, et al.
Publicado: (2021)

Time trend analysis and demographic features of inflammatory bowel disease in Tehran
por: Balaii, Hedieh, et al.
Publicado: (2015)

Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?
por: Baradaran Ghavami, Shaghayegh, et al.
Publicado: (2021)

Polyp detection rate and pathological features in patients undergoing a comprehensive colonoscopy screening
por: Asadzadeh Aghdaei, Hamid, et al.
Publicado: (2017)

The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study
por: Olfatifar, Meysam, et al.
Publicado: (2021)

Intestinal microbiota changes pre- and post-fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection among Iranian patients with concurrent inflammatory bowel disease
por: Gholam-Mostafaei, Fahimeh Sadat, et al.
Publicado: (2023)

Berberis Fruit Extract and Biochemical Parameters in Patients With Type II Diabetes
por: Moazezi, Zolikha, et al.
Publicado: (2014)

In vitro antioxidant effects of barberry fruit extracts
por: Qujeq, Durdi, et al.
Publicado: (2012)

The Entrapment Ability of Aqueous and Ethanolic Extract of Teucrium Polium: Glucose Diffusion into the External Solution
por: Qujeq, Durdi, et al.
Publicado: (2013)

Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
por: Abdehagh, Mohammad, et al.
Publicado: (2021)

Introduction of inflammatory bowel disease biomarkers panel using protein-protein interaction (PPI) network analysis
por: Asadzadeh-Aghdaee, Hamid, et al.
Publicado: (2016)

TGF-β1 polymorphisms -509 C>T and +915 G>C and risk of pancreatic cancer
por: Behboudi Farahbakhsh, Faegheh, et al.
Publicado: (2017)

Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent Clostridioides difficile Infection with Underlying Inflammatory Bowel Disease: A Pilot Study
por: Azimirad, Masoumeh, et al.
Publicado: (2022)

Signature of Gut Microbiome by Conventional and Advanced Analysis Techniques: Advantages and Disadvantages
por: Rezasoltani, Sama, et al.
Publicado: (2020)

From inflammatory bowel disease to colorectal cancer: what’s the role of miRNAs?
por: Vaghari-Tabari, Mostafa, et al.
Publicado: (2022)

Evaluation of IL-17B and IL-17F mRNA expression in peripheral blood mononuclear cells and association with clinical outcome of IBD patients
por: Safari, Mohammad Taghi, et al.
Publicado: (2017)

Evaluation of the mTORC activity in the presence of Toxoplasma gondii and azathioprine in human monocyte cell line
por: Nemati, Sara, et al.
Publicado: (2023)

Contribution of NOTCH signaling pathway along with TNF-α in the intestinal inflammation of ulcerative colitis
por: Ghorbaninejad, Mahsa, et al.
Publicado: (2019)

Detailed analysis of total colectomy on health-related quality of life in adult patients with ulcerative colitis
por: Asadzadeh Aghdaei, Hamid, et al.
Publicado: (2017)

IBD Patients Could Be Silent Carriers for Novel Coronavirus and Less Prone to its Severe Adverse Events: True or False?
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2020)

Serological response to SARS‐CoV‐2 is attenuated in patients with inflammatory bowel disease and can affect immunization
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j72sprec1tak2iu96qimpokukp